Emily Tomlinson, MD

Emily Tomlinson
CLINICAL FELLOW
M_PEDS-ONCOLOGY

I am a clinical pediatric hematology/oncology fellow at the University of California San Francisco. I have a background in providing medical care to underserved populations that has complemented my pediatric residency training. As I narrowed my specialty interest in hematology/oncology, I have continued to cultivate my clinical area of research interest in improving outcomes in leukemia, mitigating toxicity and further understanding poor health outcomes in underserved populations. I have joined Dr. Serine Avagyan’s Lab at UCSF Institute for Regenerative Medicine to explore the role of environmental risk factors associated with adverse social determinants of health in the prenatal origin of leukemia-predisposing clones in utero through inflammatory pathway upregulation. Unlike many poor prognostic predictors of B-ALL, environmental risk factors are modifiable. Understanding inflammatory pathways involved with environmental stressors would allow for targeting protective biologic mechanisms, to one day alter the course of pre-leukemia by early identification and prevention of progression.

Publications

Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel.

Blood advances

Naik S, Selukar S, Talleur AC, Deshpande S, Llaurador Caraballo G, Fabrizio VA, Rouce RH, Zeng XL, Vatsayan A, Rossoff J, Pacenta HL, John S, Phillips CL, Talano JM, Moskop A, Verneris MR, Myers GD, Hall EM, Karras NA, Bonifant CL, Qayed M, Bakinowski E, Keating A, Baumeister SHC, Tomilson E, Hermiston ML, Satwani P, Krupski C, Chinnabhandar V, Stefanski HE, Egeler E, Curran KJ, Laetsch TW, Mackall CL, Prabhu S, Nguyen K, Baggott C, Schultz LM, McNerney KO